// App-Quantinova.ai

: Congenital Aspirin-like Defect As a Result of Autosomal Recessive Variants in PTGS1

Researchers

Presenter

  • Suthesh Sivapalaratnam

Principal Investigators

  • Hayman Melissa

  • Claire Lentaigne

  • Melissa Chan

  • Marilena Crescente

  • Harriet Allan

  • Katherine Wedderburn

  • Moghees Hanif

  • Ernest Turro

  • Dan P Hart

  • Kathleen Freson

  • Kate Downes

  • Willem Ouwehand

  • Michael Laffan

  • Tim Warner

Medical Centers

  • Center for Immunobiology, QMUL, London, United Kingdom

  • Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  • Centre for Haematology, Imperial Collegel, London, United Kingdom

  • Royal London Haemophilia Centre, Barts and the London School of Medicine and Dentistry, London, United Kingdom

  • Cardiovascular Diseases, Catholic University of Leuven, Leuven, Belgium

  • INIVATA, Cambridge, United Kingdom

  • Centre for Haematology, Department of Medicine, Imperial College London, London, United Kingdom

Locations

  • United Kingdom

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • Prostaglandin D2

  • Prostaglandin E2

  • Cyclooxygenase-1

  • Thromboxane A2 Receptor

Drug/Treatment

  • Prostaglandin

  • Epinephrine

  • Adrenaclick

  • Aspirin

  • Albyl-E

  • Dinoprostone

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A